captopril has been researched along with muramidase in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Miselis, J; Siminiak, T; Wysocki, H | 1 |
| de Zeeuw, D; Grijpstra, F; Kok, RJ; Meijer, DK; Moolenaar, F; Walthuis, RB | 1 |
| de Zeeuw, D; Grijpstra, F; Haverdings, RF; Koiter, J; Kok, RJ; Meijer, DK; Moolenaar, F | 1 |
| De Zeeuw, D; Haas, M; Haverdings, RF; Meijer, DK; Moolenaar, F; Navis, G; Van Loenen-Weemaes, AM | 1 |
| Haas, M; Kok, RJ; Meijer, DK; Moolenaar, F; Poelstra, K; Prakash, J; Proost, JH; van Loenen-Weemaes, AM | 1 |
| Haas, M; Kok, RJ; Meijer, DK; Moolenaar, F; Prakash, J; Proost, JH; van Loenen-Weemaes, A | 1 |
| de Zeeuw, D; Henning, RH; Kluppel, CA; Kok, RJ; Moolenaar, F; Prakash, J; van Dokkum, RP; Windt, WA | 1 |
| Bhunia, A; Han, J; Jin, L; Liu, C; Liu, M; Siebert, HC; Yan, M; Zhang, N; Zhang, Q; Zhang, R | 1 |
8 other study(ies) available for captopril and muramidase
| Article | Year |
|---|---|
Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Degranulation; Enalaprilat; Female; Humans; In Vitro Techniques; Lisinopril; Male; Middle Aged; Muramidase; Neutrophils; Peroxidase; Ramipril; Spectrophotometry; Zymosan | 1994 |
Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Drug Delivery Systems; Kidney; Male; Metabolic Clearance Rate; Muramidase; Prodrugs; Rats; Rats, Wistar; Time Factors | 1999 |
Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Drug Delivery Systems; Enzyme Activation; Infusions, Intravenous; Kidney; Male; Muramidase; Prodrugs; Rats; Rats, Wistar | 2002 |
Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Immunohistochemistry; Injections, Intravenous; Kidney; Male; Muramidase; Nephrotic Syndrome; Rats; Rats, Wistar; Regional Blood Flow | 2002 |
Renal-selective delivery and angiotensin-converting enzyme inhibition by subcutaneously administered captopril-lysozyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Captopril; Doxorubicin; Drug Delivery Systems; Injections, Subcutaneous; Kidney; Male; Muramidase; Nephrosis; Proteinuria; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar | 2005 |
Renal targeting of captopril using subcutaneous administration of captopril-lysozyme conjugate.
Topics: Absorption; Animals; Captopril; Injections, Subcutaneous; Kidney; Muramidase; Rats | 2005 |
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Kidney; Kidney Diseases; Male; Muramidase; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Wistar; Sodium, Dietary | 2004 |
Attenuation of Human Lysozyme Amyloid Fibrillation by ACE Inhibitor Captopril: A Combined Spectroscopy, Microscopy, Cytotoxicity, and Docking Study.
Topics: Amyloid; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Muramidase; Spectrum Analysis | 2021 |